These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19331436)

  • 1. The effect of statins on the no-reflow phenomenon: an observational study in patients with hyperglycemia before primary angioplasty.
    Zhao JL; Yang YJ; Pei WD; Sun YH; Chen JL
    Am J Cardiovasc Drugs; 2009; 9(2):81-9. PubMed ID: 19331436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic pretreatment of ACEI reduces no-reflow in patients with acute myocardial infarction treated with primary angioplasty.
    Zhao JL; Yang YJ; Zhang YH; Pei WD; Sun YH; Chen JL; Gao RL
    Clin Cardiol; 2007 Mar; 30(3):130-4. PubMed ID: 17385720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic pretreatment of metformin is associated with the reduction of the no-reflow phenomenon in patients with diabetes mellitus after primary angioplasty for acute myocardial infarction.
    Zhao JL; Fan CM; Yang YJ; You SJ; Gao X; Zhou Q; Pei WD
    Cardiovasc Ther; 2013 Feb; 31(1):60-4. PubMed ID: 21884027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and long-term prognosis of angiographic slow/no-reflow phenomenon during emergency percutaneous coronary intervention for ST-elevated acute myocardial infarction.
    Dong-bao L; Qi H; Zhi L; Shan W; Wei-ying J
    Clin Cardiol; 2010 Dec; 33(12):E7-12. PubMed ID: 21184547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction.
    Iwakura K; Ito H; Kawano S; Okamura A; Kurotobi T; Date M; Inoue K; Fujii K
    Eur Heart J; 2006 Mar; 27(5):534-9. PubMed ID: 16401674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of chronic pre-treatment of statins on the level of systemic inflammation and myocardial perfusion in patients undergoing primary angioplasty.
    Oduncu V; Tanalp AC; Erkol A; Sırma D; Dündar C; Akgün T; Türkyilmaz E; Kılıçgedik A; Gözübüyük G; Tigen K; Izgi A; Kirma C
    Am J Cardiol; 2011 Jan; 107(2):179-85. PubMed ID: 21129710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction.
    Iwakura K; Ito H; Ikushima M; Kawano S; Okamura A; Asano K; Kuroda T; Tanaka K; Masuyama T; Hori M; Fujii K
    J Am Coll Cardiol; 2003 Jan; 41(1):1-7. PubMed ID: 12570936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Admission hyperglycemia and TIMI frame count in primary percutaneous coronary intervention.
    Yildiz A; Arat-Ozkan A; Kocas C; Abaci O; Coskun U; Bostan C; Olcay A; Akturk F; Okcun B; Ersanli M; Gurmen T
    Angiology; 2012 Jul; 63(5):325-9. PubMed ID: 21873345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Wu X; Mintz GS; Xu K; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW; Maehara A
    JACC Cardiovasc Interv; 2011 May; 4(5):495-502. PubMed ID: 21596321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of statins on contrast-induced nephropathy in patients with acute myocardial infarction treated with primary angioplasty.
    Zhao JL; Yang YJ; Zhang YH; You SJ; Wu YJ; Gao RL
    Int J Cardiol; 2008 Jun; 126(3):435-6. PubMed ID: 17462753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic pretreatment of angiotensin-converting receptor blocker on no-reflow phenomenon in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Hu T; Wang HC; Wang RT; Lv AL; Luan RH; Li CX; Cheng HX; Xia CH; Tao L
    Cardiovasc Ther; 2013 Jun; 31(3):e7-e11. PubMed ID: 22953997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction.
    Erkol A; Oduncu V; Pala S; Kızılırmak F; Kılıcgedik A; Yılmaz F; Güler A; Karabay CY; Kırma C
    Atherosclerosis; 2012 Mar; 221(1):254-9. PubMed ID: 22265272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction.
    Iwakura K; Ito H; Kawano S; Shintani Y; Yamamoto K; Kato A; Ikushima M; Tanaka K; Kitakaze M; Hori M; Higashino Y; Fujii K
    J Am Coll Cardiol; 2001 Aug; 38(2):472-7. PubMed ID: 11499740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
    Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of statin therapy before Q-wave myocardial infarction on myocardial perfusion.
    Hoffmann R; Haager P; Suliman H; Christott P; Radke P; Blindt R; Kelm M
    Am J Cardiol; 2008 Jan; 101(2):139-43. PubMed ID: 18178395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling.
    Niccoli G; Cosentino N; Lombardo A; Sgueglia GA; Spaziani C; Fracassi F; Cataneo L; Minelli S; Burzotta F; Maria Leone A; Porto I; Trani C; Crea F
    Coron Artery Dis; 2011 Nov; 22(7):507-14. PubMed ID: 21857508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of reactive hyperemia after coronary recanalization on myocardial tissue reperfusion by thrombolysis in myocardial infarction flow grade in acute myocardial infarction.
    Okamura A; Ito H; Iwakura K; Kawano S; Kurotobi T; Date M; Inoue K; Ogihara T; Fujii K
    Am J Cardiol; 2006 Mar; 97(5):617-23. PubMed ID: 16490424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Post primary percutaneous coronary intervention no-reflow in patients with acute myocardial infarction: contributing factors and long-term prognostic impact].
    Han YL; Deng J; Jing QM; Wang SL; Ma YY; Luan B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):483-6. PubMed ID: 16842659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of prior use of atorvastatin on coronary blood flow after primary percutaneous coronary intervention in patients presenting with acute myocardial infarction.
    Celik T; Kursaklioglu H; Iyisoy A; Kose S; Kilic S; Amasyali B; Kardesoglu E; Isik E
    Coron Artery Dis; 2005 Aug; 16(5):321-6. PubMed ID: 16000891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of statin therapy on reperfusion arrhythmia in patients who underwent successful primary angioplasty.
    Zhao JL; Yang YJ; Pei WD; Sun YH; Chen JL; Gao RL
    Clin Res Cardiol; 2008 Mar; 97(3):147-51. PubMed ID: 18049831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.